Steve Wigginton, CEO, Valence Health at Evolent Health, Inc. (EVH), sold 6,000 shares at $23.11 ($139K) on 2017-04-03, disclosed to the SEC on 2017-04-05.
Open-market sale of $139k EVH by CEO, Valence Health. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.11 | 5,300 | $122K | 88.2% |
| 2 | $23.41 | 700 | $16K | 11.8% |
| Total | $23.14 avg | 6,000 | $139K | 100% |
| Filing → |
| EVH | SELL | 2017-06-08 | $25K | — | Filing → |
| EVH | SELL | 2017-06-05 | $145K | — | Filing → |
| EVH | SELL | 2017-05-23 | $331K | — | Filing → |